Results 121 to 130 of about 59,669 (311)
We present a case of a syncopal episode resulting from significant QT interval prolongation in a patient on hydroxychloroquine for the treatment of systemic lupus erythematosus and end stage renal disease.
John P. O’Laughlin+2 more
doaj +1 more source
Screening for hydroxychloroquine retinal toxicity: Is it necessary? [PDF]
C D Morsman+4 more
openalex +1 more source
Erythematoviolaceous Papules and Plaques on Sun‐Exposed Areas
JEADV Clinical Practice, EarlyView.
Ana C. Martín‐Zamora+3 more
wiley +1 more source
Retinal toxicity in long-term hydroxychloroquine treatment [PDF]
Myron Mavrikakis+4 more
openalex +1 more source
Malignancies and immunoglobulin G4‐related disease
Immunoglobulin G4‐related disease (IgG4‐RD) is associated with increased cancer risk. Malignancies affect both IgG4‐RD involved organs, such as the lung, pancreas, bile duct, and prostate, and noninvolved organs, such as the gastrointestinal duct. B‐cell neoplasms constitute a proportion of the malignancies linked to this disease.
Jingna Li, Wen Zhang
wiley +1 more source
Influence of hydroxychloroquine on the bioavailability of oral metoprolol [PDF]
Mika Somer+5 more
openalex +1 more source
Journal of the Royal Statistical Society: Series A (Statistics in Society), Volume 185, Issue 4, Page 1834-1835, October 2022.
Kuldeep Kumar
wiley +1 more source
Early induction of apoptosis in B‐chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase‐3 and no protection by survival factors [PDF]
Laurence Lagneaux+5 more
openalex +1 more source
Recent multi‐omics studies have demonstrated that belimumab specifically targets naïve B cells and a subset of memory B cells. This observation is consistent with belimumab's established efficacy and safety profile. Abstract Belimumab is an antibody targeting the cytokine B‐cell activating factor (BAFF), which is crucial for B cell differentiation, and
Keishi Fujio+5 more
wiley +1 more source
Background: Laboratory and observational data suggest that hydroxychloroquine (HCQ) has biological activity against SARS-CoV-2, potentially permitting its use for disease prevention.
Arezoo Chouhdari
doaj +1 more source